Recent Developments

Posted: 24 Jun 2025

Upcoming Events for Late 2025

Where to find us

We’re pleased to share a few of the key industry events we’ll be attending in the second half of 2025. These conferences are a great opportunity to connect, collaborate, and stay at the forefront of innovation in clinical research and real-world evidence.

Read More

Posted: 5 Mar 2025

Micron completes successful Phase 1b trial for UK Biotech company

Micron has successfully completed a Phase 1b clinical trial on behalf of a UK-based biotech company, demonstrating its our continued expertise in performing clinical research to high regulatory and ethical standards.

full details about the successful trial

Posted: 28 Feb 2025

Successful presence for Micron at the 9th AMR Conference, Basel

Thank you to all the visitors to ESCMID 2025 Booth 11 whose presence helped make it a particularly busy and stimulating meeting to attend.

Read More

Posted: 5 Feb 2025

Chris Cooke has joined Micron as CFO

We are delighted to announce that Chris Cooke has joined Micron as CFO for the whole group

Posted: 5 Feb 2025

Consultancy and study design

Consultancy and study design for a new, rapid antimicrobial susceptibility testing system

Posted: 24 Jan 2025

Upgraded ATLAS AMR database

Upgraded ATLAS AMR database released (atlas-surveillance.com) with nearly 1 million records included, covering 20 years of data collection

Posted: 24 Jan 2025

LogicTrials completes move

LogicTrials completes move to new, expanded facility in Pretoria, serving South Africa and beyond for depot handling of clinical trial and logistic materials

Posted: 23 Jan 2025

Phase II study in hospitalised pneumonia

Phase II study in hospitalised pneumonia expanding in 2025

Posted: 23 Jan 2025

Innovative RWE study on hospital infection (CODAR)

Innovative RWE study on hospital infection (CODAR), collecting data directly from EHRs on >8000 patients in 5 countries, completed successfully

Posted: 22 Jan 2025

Multi-country Phase Ib study completed

Multi-country Phase Ib study in patients with chronic low back pain and vertebral oedema completes recruitment

Posted: 22 Jan 2025

Phase II MDR-TB study completed

Phase II study in multidrug-resistant tuberculosis (MDR-TB) in South Africa completed successfully, with 122 patients recruited